isoproterenol has been researched along with Malignant Melanoma in 6 studies
Isoproterenol: Isopropyl analog of EPINEPHRINE; beta-sympathomimetic that acts on the heart, bronchi, skeletal muscle, alimentary tract, etc. It is used mainly as bronchodilator and heart stimulant.
isoprenaline : A secondary amino compound that is noradrenaline in which one of the hydrogens attached to the nitrogen is replaced by an isopropyl group. A sympathomimetic acting almost exclusively on beta-adrenergic receptors, it is used (mainly as the hydrochloride salt) as a bronghodilator and heart stimulant for the management of a variety of cardiac disorders.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Using pharmacological approaches, evaluation of Ki-67 expression by flow cytometry and luciferase-based cAMP assay, we found that treatment with isoproterenol, a β-AR agonist, increased cAMP levels in B16F10 melanoma cells without affecting cell proliferation." | 4.12 | Crosstalk between β2- and α2-Adrenergic Receptors in the Regulation of B16F10 Melanoma Cell Proliferation. ( Ambrosio, C; Ascione, B; Grò, MC; Maccari, S; Marano, G; Matarrese, P; Molinari, P; Stati, T; Vezzi, V; Vona, R, 2022) |
| "Different pharmacologic drugs (isadrin, obsidan, phentolamine) changing adrenergic processes are shown to have different effect on the growth and development of lung metastases." | 3.67 | [Changes in the metastasis of experimental tumors and in the antimetastatic effect of cytostatics in their pharmacological action on adrenergic processes]. ( Balitskiĭ, KP; Riabukha, VN; Smelkova, MI; Veksler, IG, 1984) |
| "3 mM) moderately increased the tyrosinase activity of cultured human melanoma cells, while another beta-adrenoceptor agonist, terbutaline (1-3 mM) and a catechol compound, dopac (0." | 3.67 | Stimulation of tyrosinase by dihydroxy phenyl derivatives. ( Karg, E; Rorsman, H; Rosengren, E, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (66.67) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Matarrese, P | 1 |
| Maccari, S | 1 |
| Ascione, B | 1 |
| Vona, R | 1 |
| Vezzi, V | 1 |
| Stati, T | 1 |
| Grò, MC | 1 |
| Marano, G | 1 |
| Ambrosio, C | 1 |
| Molinari, P | 1 |
| Blagoeva, PM | 1 |
| Balansky, RM | 1 |
| Veksler, IG | 1 |
| Riabukha, VN | 1 |
| Smelkova, MI | 1 |
| Balitskiĭ, KP | 1 |
| Nilius, B | 1 |
| Böhm, T | 1 |
| Wohlrab, W | 1 |
| Karg, E | 2 |
| Johansson, LH | 1 |
| Hindemith-Augustsson, A | 1 |
| Rosengren, E | 2 |
| Rorsman, H | 2 |
6 other studies available for isoproterenol and Malignant Melanoma
| Article | Year |
|---|---|
Crosstalk between β2- and α2-Adrenergic Receptors in the Regulation of B16F10 Melanoma Cell Proliferation.
Topics: Adrenergic beta-Agonists; Cell Line, Tumor; Cell Proliferation; Humans; Isoproterenol; Melanoma; Pro | 2022 |
Effect of theophyllin and isoproterenol on cAMP level in melanotic and amelanotic hamster melanomas.
Topics: Animals; Cell Differentiation; Cricetinae; Cyclic AMP; Isoproterenol; Male; Melanoma; Mesocricetus; | 1983 |
[Changes in the metastasis of experimental tumors and in the antimetastatic effect of cytostatics in their pharmacological action on adrenergic processes].
Topics: Animals; Antineoplastic Agents; Cyclophosphamide; Drug Evaluation, Preclinical; Drug Therapy, Combin | 1984 |
Properties of a potassium-selective ion channel in human melanoma cells.
Topics: alpha-MSH; Cyclic AMP; Electric Conductivity; Electrophysiology; Humans; Isoproterenol; Melanoma; Po | 1990 |
Adenylate cyclase activity in homogenates of human melanoma cells. Effect of alpha-MSH and isoprenaline.
Topics: Adenylyl Cyclases; Cells, Cultured; Cyclic AMP; Guanosine Triphosphate; Humans; Isoproterenol; Melan | 1989 |
Stimulation of tyrosinase by dihydroxy phenyl derivatives.
Topics: 3,4-Dihydroxyphenylacetic Acid; Catechol Oxidase; Cell Line; Enzyme Activation; Humans; Isoprotereno | 1989 |